Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Alexander Pickett
Managing Director at Juvenescence
Alexander Pickett is Managing Director at Juvenescence, where he oversees new opportunity onboarding. Since 2014, he has worked with Juvenescence founding partners Greg, Jim, and Declan at Mediqventures, Ltd., a multi-family investment partnership and merchant bank where he supported existing investments at Portage Biotech Inc., including Portage Pharma Ltd. and Biohaven (NYSE:BHVN).
Alexander worked with Ian Walters to help found SalvaRx Limited, a cancer immunotherapy-focused investment company that was later merged into Portage Biotech.
Visit website: https://juvlabs.com/pages/alexander-pickett
See also
Details last updated 07-Apr-2023
Alexander Pickett News
Alexander Pickett is also referenced in the following:
Age-Related Disease Therapeutics Summit
31-May-2023 to 02-Jun-2023
Event about aging and aging related diseases organized by Hanson Wade
